Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reproducible and Characterized Method for Ponatinib Encapsulation into Biomimetic Lipid Nanoparticles as a Platform for Multi-Tyrosine Kinase-Targeted Therapy.
Zinger A, Baudo G, Naoi T, Giordano F, Lenna S, Massaro M, Ewing A, Kim HR, Tasciotti E, Yustein JT, Taraballi F. Zinger A, et al. Among authors: yustein jt. ACS Appl Bio Mater. 2020 Oct 19;3(10):6737-6745. doi: 10.1021/acsabm.0c00685. Epub 2020 Sep 2. ACS Appl Bio Mater. 2020. PMID: 35019338 Free article.
Recent Insights into Therapy Resistance in Osteosarcoma.
Prudowsky ZD, Yustein JT. Prudowsky ZD, et al. Among authors: yustein jt. Cancers (Basel). 2020 Dec 30;13(1):83. doi: 10.3390/cancers13010083. Cancers (Basel). 2020. PMID: 33396725 Free PMC article. Review.
Overcoming PD-1 Inhibitor Resistance with a Monoclonal Antibody to Secreted Frizzled-Related Protein 2 in Metastatic Osteosarcoma.
Nasarre P, Garcia DI, Siegel JB, Bonilla IV, Mukherjee R, Hilliard E, Chakraborty P, Nasarre C, Yustein JT, Lang M, Jaffa AA, Mehrotra S, Klauber-DeMore N. Nasarre P, et al. Among authors: yustein jt. Cancers (Basel). 2021 May 30;13(11):2696. doi: 10.3390/cancers13112696. Cancers (Basel). 2021. PMID: 34070758 Free PMC article.
Integrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancer.
Thaiparambil J, Dong J, Grimm SL, Perera D, Ambati CSR, Putluri V, Robertson MJ, Patel TD, Mistretta B, Gunaratne PH, Kim MP, Yustein JT, Putluri N, Coarfa C, El-Zein R. Thaiparambil J, et al. Among authors: yustein jt. Cancer Med. 2023 Jan;12(1):584-596. doi: 10.1002/cam4.4933. Epub 2022 Jun 8. Cancer Med. 2023. PMID: 35676822 Free PMC article.
64 results